Boostrix
Boostrix is a medicine authorised by Swissmedic under authorisation number 637. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 August 2000 and the authorisation is valid without a time limit. ATC code J07AJ52 places the medicine in the group Vaccines.
| Authorisation number | 637 |
|---|---|
| Name | Boostrix |
| Full name | Boostrix, Injektionssuspension |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07AJ52 |
| First authorisation | 10 August 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Boostrix, Injektionssuspension | B | 10 August 2000 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 1 | Fertigspritze(n) | J07AJ52 | 08.08. | B |
| 4 | 10 | Fertigspritze(n) | J07AJ52 | 08.08. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Boostrix authorised in Switzerland?
Yes. Boostrix is authorised by Swissmedic under authorisation number 637, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Boostrix have?
Boostrix is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Boostrix?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.